vs
太平洋生物科学（ASMB）与Rhinebeck Bancorp, Inc.（RBKB）财务数据对比。点击上方公司名可切换其他公司
Rhinebeck Bancorp, Inc.的季度营收约是太平洋生物科学的1.3倍（$13.5M vs $10.8M），Rhinebeck Bancorp, Inc.净利率更高（17.3% vs -85.2%，领先102.5%），Rhinebeck Bancorp, Inc.同比增速更快（1701.1% vs 57.6%），Rhinebeck Bancorp, Inc.自由现金流更多（$10.9M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Rhinebeck Bancorp, Inc.是总部位于美国纽约的区域性银行控股企业，旗下运营莱茵贝克银行，主要面向纽约哈德逊谷地区的个人消费者与中小企业提供储蓄、贷款、抵押贷款、财富管理等零售及商业金融服务。
ASMB vs RBKB — 直观对比
营收规模更大
RBKB
是对方的1.3倍
$10.8M
营收增速更快
RBKB
高出1643.4%
57.6%
净利率更高
RBKB
高出102.5%
-85.2%
自由现金流更多
RBKB
多$26.1M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $13.5M |
| 净利润 | $-9.2M | $2.3M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 21.7% |
| 净利率 | -85.2% | 17.3% |
| 营收同比 | 57.6% | 1701.1% |
| 净利润同比 | 4.3% | 188.0% |
| 每股收益（稀释后） | $-0.72 | $0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBRBKB
| Q4 25 | — | $13.5M | ||
| Q3 25 | $10.8M | $14.0M | ||
| Q2 25 | $9.6M | $13.1M | ||
| Q1 25 | $9.4M | $12.8M | ||
| Q4 24 | $7.4M | $750.0K | ||
| Q3 24 | $6.8M | $773.0K | ||
| Q2 24 | $8.5M | $10.7M | ||
| Q1 24 | $5.8M | $10.4M |
净利润ASMBRBKB
| Q4 25 | — | $2.3M | ||
| Q3 25 | $-9.2M | $2.7M | ||
| Q2 25 | $-10.2M | $2.7M | ||
| Q1 25 | $-8.8M | $2.3M | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $-9.6M | $-8.1M | ||
| Q2 24 | $-11.2M | $975.0K | ||
| Q1 24 | $-9.1M | $1.1M |
营业利润率ASMBRBKB
| Q4 25 | — | 21.7% | ||
| Q3 25 | -100.9% | 23.9% | ||
| Q2 25 | -115.2% | 26.6% | ||
| Q1 25 | -105.5% | 22.9% | ||
| Q4 24 | — | -444.9% | ||
| Q3 24 | -160.1% | -1332.3% | ||
| Q2 24 | -143.0% | 11.8% | ||
| Q1 24 | -185.5% | 13.9% |
净利率ASMBRBKB
| Q4 25 | — | 17.3% | ||
| Q3 25 | -85.2% | 19.3% | ||
| Q2 25 | -105.9% | 20.8% | ||
| Q1 25 | -93.6% | 17.9% | ||
| Q4 24 | — | -353.9% | ||
| Q3 24 | -140.4% | -1042.9% | ||
| Q2 24 | -130.7% | 9.2% | ||
| Q1 24 | -156.9% | 10.8% |
每股收益（稀释后）ASMBRBKB
| Q4 25 | — | $0.21 | ||
| Q3 25 | $-0.72 | $0.25 | ||
| Q2 25 | $-1.33 | $0.25 | ||
| Q1 25 | $-1.17 | $0.21 | ||
| Q4 24 | — | $-0.24 | ||
| Q3 24 | $-1.51 | $-0.75 | ||
| Q2 24 | $-1.98 | $0.09 | ||
| Q1 24 | $-1.66 | $0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $136.9M |
| 总资产 | $240.0M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBRBKB
| Q4 25 | — | — | ||
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $18.7M | — |
股东权益ASMBRBKB
| Q4 25 | — | $136.9M | ||
| Q3 25 | $182.7M | $133.0M | ||
| Q2 25 | $18.1M | $129.0M | ||
| Q1 25 | $27.1M | $126.0M | ||
| Q4 24 | $33.4M | $121.8M | ||
| Q3 24 | $26.0M | $122.7M | ||
| Q2 24 | $34.7M | $116.2M | ||
| Q1 24 | $32.6M | $114.3M |
总资产ASMBRBKB
| Q4 25 | — | $1.3B | ||
| Q3 25 | $240.0M | $1.3B | ||
| Q2 25 | $80.8M | $1.3B | ||
| Q1 25 | $99.0M | $1.3B | ||
| Q4 24 | $119.2M | $1.3B | ||
| Q3 24 | $100.3M | $1.3B | ||
| Q2 24 | $115.3M | $1.3B | ||
| Q1 24 | $119.9M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $11.7M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $10.9M |
| 自由现金流率自由现金流/营收 | -140.7% | 80.6% |
| 资本支出强度资本支出/营收 | 0.4% | 6.3% |
| 现金转化率经营现金流/净利润 | — | 5.03× |
| 过去12个月自由现金流最近4个季度 | — | $19.4M |
8季度趋势，按日历期对齐
经营现金流ASMBRBKB
| Q4 25 | — | $11.7M | ||
| Q3 25 | $-15.1M | $2.2M | ||
| Q2 25 | $-16.8M | $2.4M | ||
| Q1 25 | $-23.4M | $4.3M | ||
| Q4 24 | $-51.1M | $8.5M | ||
| Q3 24 | $-15.2M | $-3.6M | ||
| Q2 24 | $-17.1M | $12.0M | ||
| Q1 24 | $-18.4M | $-3.5M |
自由现金流ASMBRBKB
| Q4 25 | — | $10.9M | ||
| Q3 25 | $-15.2M | $2.0M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $4.2M | ||
| Q4 24 | $-51.1M | $7.7M | ||
| Q3 24 | — | $-3.6M | ||
| Q2 24 | $-17.1M | $11.8M | ||
| Q1 24 | $-18.4M | $-3.7M |
自由现金流率ASMBRBKB
| Q4 25 | — | 80.6% | ||
| Q3 25 | -140.7% | 14.5% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | -695.2% | 1023.9% | ||
| Q3 24 | — | -469.0% | ||
| Q2 24 | -200.6% | 111.1% | ||
| Q1 24 | -317.7% | -36.0% |
资本支出强度ASMBRBKB
| Q4 25 | — | 6.3% | ||
| Q3 25 | 0.4% | 1.4% | ||
| Q2 25 | 0.0% | 1.4% | ||
| Q1 25 | 0.0% | 0.9% | ||
| Q4 24 | 0.4% | 105.5% | ||
| Q3 24 | 0.0% | 6.3% | ||
| Q2 24 | 0.2% | 1.2% | ||
| Q1 24 | 0.2% | 2.3% |
现金转化率ASMBRBKB
| Q4 25 | — | 5.03× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 0.89× | ||
| Q1 25 | — | 1.89× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.27× | ||
| Q1 24 | — | -3.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
